COX-2 Inhibitory Treatment in Chronic Lymphocytic Leukemia: A Preliminary Clinical Study
- 1 July 2004
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 45 (7) , 1495-1496
- https://doi.org/10.1080/10428190410001663608
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2Proceedings of the National Academy of Sciences, 2003
- Celecoxib activates a novel mitochondrial apoptosis signaling pathwayThe FASEB Journal, 2003
- Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent pathwaysLung Cancer, 2003
- Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemiaBlood, 2002
- Synergistic Cytotoxicity and Apoptosis of JTE-522, a Selective Cyclooxygenase-2 Inhibitor, and 5-fluorouracil Against Bladder CancerJournal of Urology, 2002
- Bone marrow cyclooxygenase‐2 levels are elevated in chronic‐phase chronic myeloid leukaemia and are associated with reduced survivalBritish Journal of Haematology, 2002
- Caspase activation: The induced-proximity modelProceedings of the National Academy of Sciences, 1999
- Chronic lymphocytic leukemiaCurrent Opinion in Hematology, 1997
- Antigen‐Driven Selection of Virgin and Memory B CellsImmunological Reviews, 1986